Neurobiology of Aging
Volume 24, Issue 1 , Pages 77-84 , January 2003

Telomere shortening in T cells correlates with Alzheimer’s disease status

  • L.A Panossian

      Affiliations

    • Department of Pathology and Laboratory Medicine, UCLA School of Medicine, 10833 Le Conte Avenue, Los Angeles, CA 90095, USA
    • ,
  • V.R Porter

      Affiliations

    • Department of Neurology, UCLA School of Medicine, Los Angeles, CA 90095, USA
    • ,
  • H.F Valenzuela

      Affiliations

    • Department of Pathology and Laboratory Medicine, UCLA School of Medicine, 10833 Le Conte Avenue, Los Angeles, CA 90095, USA
    • ,
  • X Zhu

      Affiliations

    • Department of Pathology and Laboratory Medicine, UCLA School of Medicine, 10833 Le Conte Avenue, Los Angeles, CA 90095, USA
    • ,
  • Erin Reback

      Affiliations

    • Department of Neurology, UCLA School of Medicine, Los Angeles, CA 90095, USA
    • ,
  • D Masterman

      Affiliations

    • Department of Neurology, UCLA School of Medicine, Los Angeles, CA 90095, USA
    • ,
  • J.L Cummings

      Affiliations

    • Department of Neurology, UCLA School of Medicine, Los Angeles, CA 90095, USA
    • ,
  • R.B Effros

      Affiliations

    • Department of Pathology and Laboratory Medicine, UCLA School of Medicine, 10833 Le Conte Avenue, Los Angeles, CA 90095, USA
    • Molecular Biology Institute, UCLA, Los Angeles, CA 90095, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1-310-825-0748; fax: +1-310-267-2104.

Received 15 November 2001 ,Revised 3 January 2002 ,Accepted 7 March 2002.

References 

  1. Adibzadeh M, Pohla H, Rehbein A, Pawelec G. Long-term culture of monoclonal human T lymphocytes: models for immunosenescence?. Mech. Ageing Dev. 1995;83:171–183
  2. Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, Cole GM, et al.  Inflammation and Alzheimer’s disease. Neurobiol. Aging. 2000;21:383–421
  3. Allsopp RC, Vaziri H, Patterson C, Goldstein S, Yougli EV, Futcher AB. Telomere length predicts replicative capacity of human fibroblasts. Proc. Natl. Acad. Sci. U.S.A. 1992;89:10114–10118
  4. Benveniste EN. Cytokine actions in the central nervous system. Cytokine Growth Factor Rev. 1998;9:259–275
  5. Blackburn E. Structure and function of telomeres. Nature. 1991;350:569–573
  6. Blasko I, Marx F, Steiner E, Hartmann T, Grubeck-Loebenstein B. TNFalpha plus IFNgamma induce the production of Alzheimer beta-amyloid peptides and decrease the secretion of APPs. FASEB J. 1999;13:63–68
  7. Bonaccorso S, Lin A, Song C, Verkerk R, Kenis G, Bosmans E, et al.  Serotonin-immune interactions in elderly volunteers and in patients with Alzheimer’s disease (DAT): lower plasma tryptophan availability to the brain in the elderly and increased serum interleukin-6 in DAT. Aging (Milano). 1998;10:316–323
  8. Bondy B, Hofmann M, Muller-Spahn F, Witzko M, Hock C. Reduced beta-amyloid response in lymphocytes of patients with Alzheimer’s disease. Pharmacopsychiatry. 1995;28:143–146
  9. Campisi J. The role of cellular senescence in skin aging. J. Investig. Dermatol. Symp. Proc. 1998;3:1–5
  10. Campisi J, Dimri G, Hara E. Control of replicative senescence. In: Schneider Jr E, editor. Handbook of the biology of aging, 1996.
  11. Chang E, Harley CB. Telomere length as a measure of replicative histories in human vascular tissues. Proc. Natl. Acad. Sci. U.S.A. 1995;92:11190–11194
  12. Doerfler P, Shearman MS, Perlmutter RM. Presenilin-dependent gamma-secretase activity modulates thymocyte development. Proc. Natl. Acad. Sci. U.S.A. 2001;98:9312–9317
  13. Eckert A, Schindowski K, Leutner S, Luckhaus C, Touchet N, Czech C, et al.  Alzheimer’s disease-like alterations in peripheral cells from presenilin-1 transgenic mice. Neurobiol. Dis. 2001;8:331–342
  14. Effros RB. Immune system activity. In: Masoro E, Austad S, editors. Handbook of the biology of aging. San Diego: Academic Press, 2001, p. 324–50.
  15. Effros RB. Loss of CD28 expression on T lymphocytes: a marker of replicative senescence. Dev. Compar. Immunol. 1997;21:471–478
  16. Effros RB. Replicative senescence in the immune system: impact of the Hayflick Limit on T cell function in the elderly. Am. J. Hum. Gen. 1998;62:1003–1007
  17. Effros RB, Allsopp R, Chiu CP, Wang L, Hirji K, Harley CB, et al.  Shortened telomeres in the expanded CD28–CD8+ subset in HIV disease implicate replicative senescence in HIV pathogenesis. AIDS/Fast Track. 1996;10:F17–F22
  18. Effros RB, Pawelec G. Replicative senescence of T lymphocytes: does the hayflick limit lead to immune exhaustion?. Immunol. Today. 1997;18:450–454
  19. Effros RB, Zhu X, Walford RL. Stress response of senescent T lymphocytes: reduced hsp70 is independent of the proliferative block. J. Gerontol. 1994;49:B65–B70
  20. Grossmann A, Kukull WA, Jinneman JC, Bird TD, Villacres EC, Larson EB, et al.  Intracellular calcium response is reduced in CD4+ lymphocytes in Alzheimer’s disease and in older persons with Down’s syndrome. Neurobiol. Aging. 1993;14:177–185
  21. Itagaki S, McGeer PL, Akiyama H. Presence of T cytotoxic suppressor and leucocyte common antigen positive cells in Alzheimer’s disease brain tissue. Neurosci. Lett. 1988;91:259–264
  22. Joachim CL, Mori H, Selkoe DJ. Amyloid beta-protein deposition in tissues other than brain in Alzheimer’s disease. Nature. 1989;341:226–230
  23. Kell SH, Allman RM, Harrell LE, Liu T, Solvason N. Association between Alzheimer’s disease and bound autochthonous IgM on T cells. J. Am. Geriatr. Soc. 1996;44:1362–1365
  24. Ledoux S, Rebai N, Dagenais A, Shaw IT, Nalbantoglu J, Sekaly RP, et al.  Amyloid precursor protein in peripheral mononuclear cells is upregulated with cell activation. J. Immunol. 1993;150:5566–5575
  25. Mayeux R, Tang MX, Jacobs DM, Manly J, Bell K, Merchant C, et al.  Plasma amyloid beta-peptide 1–42 and incipient Alzheimer’s disease. Ann. Neurol. 1999;46:412–416
  26. Mehta PD, Pirttila T, Patrick BA, Barshatzky M, Mehta SP. Amyloid beta protein 1–40 and 1–42 levels in matched cerebrospinal fluid and plasma from patients with Alzheimer disease. Neurosci. Lett. 2001;304:102–106
  27. Monteiro J, Batliwalla F, Ostrer H, Gregersen PK. Shortened telomeres in clonaly expanded CD28–CD8+ T cells imply a replicative history that is distinct from their CD28+CD8+ counterparts. J. Immunol. 1996;156:3587–3590
  28. Nijhuis EWP, Oostervink F, Hinloopen B, Rozing J, Nagelkerken L. Differences in dexamethasone-sensitivity between lymphocytes from patients with Alzheimer’s disease and patients with multi-infarct dementia. Brain Behav. Immun. 1996;10:115–125
  29. Oshima J, Campisi J, Tannock TC, Martin GM. Regulation of c-fos expression in senescing Werner syndrome fibroblasts differs from that observed in senescing fibroblasts from normal donors. J. Cell Physiol. 1995;162:277–283
  30. Pallister C, Jung SS, Shaw I, Nalbantoglu J, Gauthier S, Cashman NR. Lymphocyte content of amyloid precursor protein is increased in Down’s syndrome and aging. Neurobiol. Aging. 1997;18:97–103
  31. Schenk D, Barbour R, Dunn W, Gordon G, Grajeda H, Guido T, et al.  Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse [see comments]. Nature. 1999;400:173–177
  32. Shalit F, Sredni B, Brodie C, Kott E, Huberman M. T lymphocyte subpopulations and activation markers correlate with severity of Alzheimer’s disease. Clin. Immunol. Immunopathol. 1995;75:246–250
  33. Stoll G, Jander S. The role of microglia and macrophages in the pathophysiology of the CNS. Prog. Neurobiol. 1999;58:233–247
  34. Trieb K, Ransmayr G, Sgonc R, Lassmann H, Grubeck-Loebenstein B. APP peptides stimulate lymphocyte proliferation in normals, but not in patients with Alzheimer’s disease. Neurobiol. Aging. 1996;17:541–547
  35. Valenzuela H, Effros RB. Telomere measurement and replicative senescence. In: Barnett YA, Barnett CR, editors. Aging: methods and protocols. Totowa (New Jersey): Humanae Press, 2000.
  36. Vaziri H, Schachter F, Uchida I, Wei L, Zhu X, Effros R, et al.  Loss of telomeric DNA during aging of normal and trisomy 21 human lymphocytes. Am. J. Hum. Genet. 1993;52:661–667
  37. von Zglinicki T. Role of oxidative stress in telomere length regulation and replicative senescence. Ann. N.Y. Acad. Sci. 2000;908:99–110
  38. von Zglinicki T, Saretzki G, Deocke W, Lotze C. Mild hyperoxia shortens telomeres and inhibits proliferation of fibroblasts: a model for senescence?. Exp. Cell Res. 1995;220:186–193
  39. Wang E. Regulation of apoptosis resistance and ontogeny of age-dependent diseases. Exp. Gerontol. 1997;32:471–484
  40. Weng NP, Palmer LD, Levine BL, Lane HC, June CH, Hodes RJ. Tales of tails: regulation of telomere length and telomerase activity during lymphocyte development, differentiation, activation, and aging. Immunol. Rev. 1997;160:43–54
  41. Weyand CM, Bryl E, Goronzy JJ. The role of T cells in rheumatoid arthritis. Arch. Immunol. Ther. Exp. (Warsz). 2000;48:429–435
  42. Xu S, Gaskin F. Increased incidence of anti-beta-amyloid autoantibodies secreted by Epstein-Barr virus transformed B cell lines from patients with Alzheimer’s disease. Mech. Ageing Dev. 1997;94:213–222
  43. Younkin SG. Amyloid beta vaccination: reduced plaques and improved cognition. Nat. Med. 2001;7:18–19
  44. Zhu H, Fu W, Mattson MP. The catalytic subunit of telomerase protects neurons against amyloid beta-peptide-induced apoptosis. J. Neurochem. 2000;75:117–124

PII: S0197-4580(02)00043-X

Neurobiology of Aging
Volume 24, Issue 1 , Pages 77-84 , January 2003

Article Tools

* Image Usage & Resolution